AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE Drug Patent Profile
✉ Email this page to a colleague
When do Aminess 5.2% Essential Amino Acids W/ Histadine patents expire, and what generic alternatives are available?
Aminess 5.2% Essential Amino Acids W/ Histadine is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aminess 5.2% Essential Amino Acids W/ Histadine
A generic version of AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE was approved as amino acids by B BRAUN on April 13th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE?
- What are the global sales for AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE?
- What is Average Wholesale Price for AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE?
Summary for AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE at DailyMed |
US Patents and Regulatory Information for AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE | amino acids | INJECTABLE;INJECTION | 018901-001 | Apr 6, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |